Galsky, Matt D.;
Grande, Enrique;
Davis, Ian D.;
De Santis, Maria;
Arranz Arija, Jose Angel;
Kikuchi, Eiji;
Mecke, Almut;
Thastrom, Ann Christine;
Bamias, Aristotelis
IMvigor130: A randomized, phase III study evaluating first-line (1L) atezolizumab (atezo) as monotherapy and in combination with platinum-based chemotherapy (chemo) in patients (pts) with locally advanced or metastatic urothelial carcinoma (mUC)
You can manage bookmarks using lists, please log in to your user account for this.
Media type:
E-Article
Title:
IMvigor130: A randomized, phase III study evaluating first-line (1L) atezolizumab (atezo) as monotherapy and in combination with platinum-based chemotherapy (chemo) in patients (pts) with locally advanced or metastatic urothelial carcinoma (mUC)
Contributor:
Galsky, Matt D.;
Grande, Enrique;
Davis, Ian D.;
De Santis, Maria;
Arranz Arija, Jose Angel;
Kikuchi, Eiji;
Mecke, Almut;
Thastrom, Ann Christine;
Bamias, Aristotelis
imprint:
American Society of Clinical Oncology (ASCO), 2018